Zimmer Biomet
About: Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Employees: 17,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
5.61% more ownership
Funds ownership: 91.7% [Q1] → 97.3% (+5.61%) [Q2]
7% less funds holding
Funds holding: 988 [Q1] → 921 (-67) [Q2]
15% less capital invested
Capital invested by funds: $20.7B [Q1] → $17.6B (-$3.1B) [Q2]
17% less repeat investments, than reductions
Existing positions increased: 298 | Existing positions reduced: 360
36% less first-time investments, than exits
New positions opened: 90 | Existing positions closed: 141
42% less funds holding in top 10
Funds holding in top 10: 12 [Q1] → 7 (-5) [Q2]
50% less call options, than puts
Call options by funds: $27.5M | Put options by funds: $55.5M
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
|
Rothschild & Co
Ed Ridley-Day
|
$130
|
Buy
Initiated
|
18 Sep 2025 |
|
RBC Capital
Shagun Singh
|
$115
|
Outperform
Maintained
|
8 Aug 2025 |
|
UBS
Danielle Antalffy
|
$96
|
Sell
Maintained
|
8 Aug 2025 |
|
Raymond James
Jayson Bedford
|
$113
|
Outperform
Maintained
|
8 Aug 2025 |
|
Evercore ISI Group
Vijay Kumar
|
$96
|
In-Line
Maintained
|
8 Jul 2025 |
Financial journalist opinion
Based on 11 articles about ZBH published over the past 30 days
